₹5,000 Monthly SIP in Nippon India Pharma Fund-Growth Plan for 15 Years
If you had started a ₹5,000/month SIP on 18 Aug 2011 and never stopped — through every crash and rally — here is exactly what happened, using Nippon India Pharma Fund-Growth Plan's actual NAV for all 181 installments.
You invested
₹9,05,000
181 installments
Value today
₹36,33,698
18 Aug 2026
Absolute gain
+₹27,28,698
+301.5%
XIRR (annualised)
16.8%
money-weighted
The journey, month by month
Worst fall on the way
-20.7%
Deepest drop from peak. This is what you had to sit through.
Corrections survived
7
Falls of 10%+ during the period. Every one recovered.
Same SIP in a fixed deposit
₹16,84,161
Modelled at historical FD rates. The fund beat FD by ₹19,49,537.
Year-by-year progress
| Year | Invested | Value | Overall gain |
|---|---|---|---|
| Year 1 (21 Aug 2012) | ₹65,000 | ₹73,404 | +12.9% |
| Year 2 (19 Aug 2013) | ₹1,25,000 | ₹1,42,848 | +14.3% |
| Year 3 (18 Aug 2014) | ₹1,85,000 | ₹2,88,910 | +56.2% |
| Year 4 (18 Aug 2015) | ₹2,45,000 | ₹4,85,405 | +98.1% |
| Year 5 (18 Aug 2016) | ₹3,05,000 | ₹5,14,563 | +68.7% |
| Year 6 (18 Aug 2017) | ₹3,65,000 | ₹4,97,658 | +36.3% |
| Year 7 (20 Aug 2018) | ₹4,25,000 | ₹7,04,567 | +65.8% |
| Year 8 (19 Aug 2019) | ₹4,85,000 | ₹6,83,398 | +40.9% |
| Year 9 (18 Aug 2020) | ₹5,45,000 | ₹11,82,014 | +116.9% |
| Year 10 (18 Aug 2021) | ₹6,05,000 | ₹17,15,904 | +183.6% |
| Year 11 (18 Aug 2022) | ₹6,65,000 | ₹16,12,976 | +142.6% |
| Year 12 (18 Aug 2023) | ₹7,25,000 | ₹20,71,737 | +185.8% |
| Year 13 (19 Aug 2024) | ₹7,85,000 | ₹30,50,279 | +288.6% |
| Year 14 (18 Aug 2025) | ₹8,45,000 | ₹32,56,972 | +285.4% |
| Year 15 (18 Aug 2026) | ₹9,05,000 | ₹36,33,698 | +301.5% |
Best year of the journey: Year 9 (+59% market move) · Toughest year: Year 6 (-13.4%)
Wealth Time Machine
Watch this exact journey as a 60-second cinematic replay
Every crash headline, every recovery — with your money in it.
Try a different amount
Try a different duration
Past performance does not guarantee future returns. This page shows the historical result of the stated SIP using Nippon India Pharma Fund-Growth Plan's published NAV (source: AMFI) between 18 Aug 2011 and 18 Aug 2026; it is educational research, not investment advice. FD comparison is modelled at historical average FD rates. Mutual fund investments are subject to market risks.